Last reviewed · How we verify

Pyridoxine plus prednisolone

Lady Hardinge Medical College · Phase 3 active Small molecule

Pyridoxine (vitamin B6) supports immune function and nervous system health while prednisolone suppresses inflammatory and immune responses through glucocorticoid receptor activation.

Pyridoxine (vitamin B6) supports immune function and nervous system health while prednisolone suppresses inflammatory and immune responses through glucocorticoid receptor activation. Used for Autoimmune or inflammatory conditions (specific indication not publicly detailed).

At a glance

Generic namePyridoxine plus prednisolone
SponsorLady Hardinge Medical College
Drug classCombination therapy (vitamin B6 + corticosteroid)
ModalitySmall molecule
Therapeutic areaImmunology / Rheumatology / Neurology
PhasePhase 3

Mechanism of action

Pyridoxine is an essential cofactor for numerous enzymatic reactions involved in immune cell function and neurotransmitter synthesis. Prednisolone is a corticosteroid that binds glucocorticoid receptors to reduce inflammation, suppress immune cell proliferation, and decrease production of pro-inflammatory cytokines. The combination likely aims to provide nutritional support while managing inflammatory or autoimmune conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: